latch-bio-1-cover-image

The CRISPR community is facing a tsunami of data but a dearth of computational tools required for their analyses. By empowering the researcher, Latch is helping remove a significant bottleneck that is currently slowing down the CRISPR research cycle, enabling the discovery of new therapies.

Nulla adipisicing do ut aliquip elit tempor fugiat. Mollit est exercitation excepteur ea consequat ullamco Lorem ex id. Ipsum nostrud Lorem dolor nisi do est in ex amet eu nostrud. Amet commodo consectetur enim nostrud dolore sint excepteur irure aliqua consectetur. Veniam occaecat et enim eiusmod qui fugiat eiusmod eiusmod laborum exercitation veniam ipsum velit. Ut veniam cupidatat ea tempor ad ad exercitation amet qui. Esse commodo sint deserunt ut elit minim sint. Amet laborum ut adipisicing minim sunt cillum anim in est ipsum aliquip anim in tempor pariatur.

industries

Infrastructure Computer Science

Progressing Science Knowledge

Milestones

Lux investment: 2021

Founders

Alfredo Andere

Kenny Workman

Kyle Giffin

Lux partners
Brandon Reeves
Tess van Stekelenburg

Latch Bio

Kim Tran
Tess van Stekelenburg
Andrew Wilson
Jasmine Rainey
Tracie Rotter
Stevie Lee
Steven Brody
Shaq Vayda
Shahin Farshchi, PhD
Segolene Scarborough
Sean Traynor
Scott Rubin
Saunaz Moradi
Samuel Arbesman, PhD
Samantha Cho
Peter Hébert
Lindsay Morris
Lan Jiang
Josh Wolfe
Grace Isford
Deena Shakir
Debbie Elsen
Danny Crichton
Cristina Morris
Chris Gates
Bree Morgan
Brandon Reeves
Brad Gritsch
Bilal Zuberi
Bibi Masara
Alex Nguyen
Adam Kalish